Show simple item record

dc.contributor.authorEyles, Jim E
dc.contributor.authorVessillier, Sandrine
dc.contributor.authorJones, Anika
dc.contributor.authorStacey, Glyn
dc.contributor.authorSchneider, Christian K
dc.contributor.authorPrice, Jack
dc.date.accessioned2019-02-05T09:35:09Z
dc.date.available2019-02-05T09:35:09Z
dc.identifier.issn02682575
dc.identifier.doi10.1002/jctb.5829
dc.identifier.urihttp://hdl.handle.net/10033/621679
dc.description.abstractRecent accelerated approvals of Chimeric Antigen Receptor T‐cell (CAR‐T) therapies targeting refractory haematological malignancies underscore the potential for this novel technology platform to provide new therapeutic options for oncology areas with high unmet medical needs. However, these powerful ‘living drugs’ are markedly different to conventional small molecule and biologic therapies on several levels. The highly complex nature and varied composition of CAR‐T based products still requires considerable investigation to resolve the best approaches to ensure reproducible and cost‐effective manufacture, clinical development, and application. This review will focus on key issues for manufacturing and quality control of these exciting new therapeutic modalities, preceded by a brief description of CAR principals and clinical development considerations. © 2018 The Authors. Journal of Chemical Technology & Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.en_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.urlhttp://doi.wiley.com/10.1002/jctb.5829en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleCell therapy products: focus on issues with manufacturing and quality control of chimeric antigen receptor T-cell therapiesen_US
dc.typeArticleen_US
dc.contributor.departmentTWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH,Feodor-Lynen Str. 7, 30625 Hannover, Germany.en_US
dc.identifier.journalJournal of Chemical Technology and Biotechnologyen_US
refterms.dateFOA2019-02-05T09:35:10Z
dc.source.journaltitleJournal of Chemical Technology & Biotechnology


Files in this item

Thumbnail
Name:
Eyles et al.pdf
Size:
389.3Kb
Format:
PDF
Description:
Open Access article

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International